guest ::
| Home > In process > The insertion of an ATTTC repeat in an Alu element hyperactivates a neurodevelopmental enhancer in spinocerebellar ataxia type 37. > print |
| Home > In process > The insertion of an ATTTC repeat in an Alu element hyperactivates a neurodevelopmental enhancer in spinocerebellar ataxia type 37. > print |
| 001 | 286090 | ||
| 005 | 20260413125809.0 | ||
| 024 | 7 | _ | |a 10.1016/j.celrep.2026.117146 |2 doi |
| 024 | 7 | _ | |a pmid:41871099 |2 pmid |
| 024 | 7 | _ | |a 2211-1247 |2 ISSN |
| 024 | 7 | _ | |a 2639-1856 |2 ISSN |
| 037 | _ | _ | |a DZNE-2026-00386 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Loureiro, Joana R |0 P:(DE-HGF)0 |b 0 |e First author |
| 245 | _ | _ | |a The insertion of an ATTTC repeat in an Alu element hyperactivates a neurodevelopmental enhancer in spinocerebellar ataxia type 37. |
| 260 | _ | _ | |a Maryland Heights, MO |c 2026 |b Cell Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1776077756_32196 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Alu elements are evolutionarily very old primate-specific interspersed repeat elements that constitute ∼11% of the human genome. They are a source of short tandem repeats (STRs), which often expand in size and cause inherited neuromuscular and neurodegenerative disorders. How expanded STR insertion mutations within Alu STRs culminate in disease remains unknown. Here, we report an Alu STR located in an intron of DAB1 that functions as a neurodevelopmental enhancer. We demonstrate that an ATTTC repeat insertion in this DAB1 Alu STR, known to cause spinocerebellar ataxia type 37 (SCA37), hyperactivates a neurodevelopmental DAB1 enhancer. Importantly, we show that neurons derived from SCA37 subjects have higher levels of DAB1 expression and that DAB1 overexpression causes abnormal axonal pathfinding in vivo. Overall, these results establish that neuronal dysregulation of a developmental DAB1 Alu STR enhancer contributes to SCA37 pathogenesis, an unexplored mechanism likely acting in many Alu STR diseases, potentially reshaping the therapeutic landscape. |
| 536 | _ | _ | |a 354 - Disease Prevention and Healthy Aging (POF4-354) |0 G:(DE-HGF)POF4-354 |c POF4-354 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a 4C-seq |2 Other |
| 650 | _ | 7 | |a CAGE |2 Other |
| 650 | _ | 7 | |a CP: genomics |2 Other |
| 650 | _ | 7 | |a CP: neuroscience |2 Other |
| 650 | _ | 7 | |a DAB1 primate-specific Alu element |2 Other |
| 650 | _ | 7 | |a SCA37 |2 Other |
| 650 | _ | 7 | |a STR |2 Other |
| 650 | _ | 7 | |a axonal pathfinding |2 Other |
| 650 | _ | 7 | |a cap analysis of gene expression |2 Other |
| 650 | _ | 7 | |a cerebellar transcriptional enhancer |2 Other |
| 650 | _ | 7 | |a circularized chromosome conformation capture sequencing |2 Other |
| 650 | _ | 7 | |a iPSN |2 Other |
| 650 | _ | 7 | |a neurodegenerative disease |2 Other |
| 650 | _ | 7 | |a pentanucleotide repeat expansion |2 Other |
| 650 | _ | 7 | |a short tandem repeat |2 Other |
| 650 | _ | 7 | |a spinocerebellar ataxia type 37 |2 Other |
| 700 | 1 | _ | |a Castro, Ana F |b 1 |
| 700 | 1 | _ | |a Figueiredo, Ana S |b 2 |
| 700 | 1 | _ | |a Eufrásio, Ana |b 3 |
| 700 | 1 | _ | |a Dhingra, Ashutosh |0 P:(DE-2719)2811729 |b 4 |u dzne |
| 700 | 1 | _ | |a Galhardo, Mafalda |b 5 |
| 700 | 1 | _ | |a Marcelino, Hugo |b 6 |
| 700 | 1 | _ | |a Rodrigues, Catarina C |b 7 |
| 700 | 1 | _ | |a Sampaio, Paula |b 8 |
| 700 | 1 | _ | |a Azevedo, Maria |b 9 |
| 700 | 1 | _ | |a Sousa, Mafalda |b 10 |
| 700 | 1 | _ | |a Dória, Sofia |b 11 |
| 700 | 1 | _ | |a Rizzu, Patrizia |0 P:(DE-2719)2810718 |b 12 |
| 700 | 1 | _ | |a Heutink, Peter |0 P:(DE-2719)2810728 |b 13 |
| 700 | 1 | _ | |a Bessa, José |b 14 |
| 700 | 1 | _ | |a Silveira, Isabel |b 15 |
| 773 | _ | _ | |a 10.1016/j.celrep.2026.117146 |g Vol. 45, no. 4, p. 117146 - |0 PERI:(DE-600)2649101-1 |n 4 |p 117146 |t Cell reports |v 45 |y 2026 |x 2211-1247 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/286090/files/DZNE-2026-00386.pdf |y Restricted |
| 856 | 4 | _ | |u https://pub.dzne.de/record/286090/files/DZNE-2026-00386.pdf?subformat=pdfa |x pdfa |y Restricted |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2811729 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 12 |6 P:(DE-2719)2810718 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2810728 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-354 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Prevention and Healthy Aging |x 0 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-11-10 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL REP : 2022 |d 2025-11-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-11-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2025-08-21T14:50:29Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2025-08-21T14:50:29Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2025-08-21T14:50:29Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-11-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2025-11-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-11-10 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-11-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-11-10 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-11-10 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CELL REP : 2022 |d 2025-11-10 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2025-11-10 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2025-11-10 |
| 920 | 1 | _ | |0 I:(DE-2719)1210002 |k AG Heutink |l Genome Biology of Neurodegenerative Diseases |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1210009 |k AG Rizzu |l Applied Genomics for Neurodegenerative Diseases |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a EDITORS |
| 980 | _ | _ | |a VDBINPRINT |
| 980 | _ | _ | |a I:(DE-2719)1210002 |
| 980 | _ | _ | |a I:(DE-2719)1210009 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|